GABAergic dysfunction in schizophrenia: New treatment strategies on the horizon

Psychopharmacology

Volumn 180, Issue 2, 2005, Pages 191-205

  Guidotti, Alessandro ^a   Auta, James ^a   Davis, John M ^a   Dong, Erbo ^a   Grayson, Dennis R ^a   Veldic, Marin ^a   Zhang, Xianquan ^a   Costa, Erminio ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Benzodiazepines; Bipolar disorder; Diazepam; GABA mimetics; GABAA receptors; Glutamic acid decarboxylase; Imidazenil; Psychoses; Reelin; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BRETAZENIL; DIAZEPAM; GABOXADOL; IMIDAZENIL; MESSENGER RNA; MUSCIMOL; ZOLPIDEM;

AMNESIA; ARTICLE; CLINICAL TRIAL; CONFUSION; DISORIENTATION; DOWN REGULATION; DRUG DEPENDENCE; DRUG TOLERANCE; GENE REPLICATION; HUMAN; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NERVE ENDING; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSYCHOSIS; PYRAMIDAL NERVE CELL; RECEPTOR BINDING; RNA TRANSLATION; SCHIZOPHRENIA; SEDATION; SIDE EFFECT;

ANIMALS; BENZODIAZEPINES; BIPOLAR DISORDER; CELL ADHESION MOLECULES, NEURONAL; CEREBRAL CORTEX; CHLORIDE CHANNELS; EXTRACELLULAR MATRIX PROTEINS; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; NERVE TISSUE PROTEINS; RECEPTORS, GABA-A; SCHIZOPHRENIA; SERINE ENDOPEPTIDASES; SYNAPTIC TRANSMISSION;

EID: 21344438862     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-2212-8     Document Type: Article

References (99)

1. Abdolmaleky HM, Cheng KH, Russo A, Smith CL, Faraone SV, Wilcox M et al (2005) Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenia patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 134:60-66
2. A receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex 6:550-560
3. Akbarian S, Kim JJ, Potkin G, Hagman JO, Tafazzoli A, Bunney WE Jr, Jones EG (1995b) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 552:258-266
4. A receptors, exhibits low tolerance and dependence liabilities in the rat. J Pharmacol Exp Ther 270:1262-1269
5. A receptors on complex behavioral processes in monkeys. Behav Pharmacol 6:323-332
6. Auta J, Guidotti A, Costa E (2000) Imidazenil prevention of alprazolam-induced acquisition in Patas monkeys is devoid of tolerance. Proc Natl Acad Sci U S A 97:2314-2319
7. Auta J, Costa E, Davis J, Guidotti A (2004) Imidazenil: a potent and safe protective agent against diisopropyl fluorophosphate toxicity. Neuropharmacology 46:397-403
8. A receptors. In: Möhler H (ed) Handbook of experimental pharmacology, vol 150. Springer, Berlin Heidelberg New York, pp 79-99
9. Benes FM (2000) Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 31:251-269
10. Benes FM, Berretta S (2001) GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1-27
11. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12:924-929
12. A receptor binding in the hippocampal formation of schizophrenic brain. Synapse 22:338-349
13. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75:1021-1031
14. Black JE, Kodish IM, Grossman AW, Klintsova AY, Orlovskaya D, Vostrikov V, Uranova N, Greenough WT (2004) Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am J Psychiatry 161:742-744
15. Busto U, Kaplan HL, Zawertailo L, Sellers EM (1994) Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans. Clin Pharmacol Ther 55:451-463
16. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260
17. Carpenter WT Jr, Buchanan RW, Kirkpatric B, Breier AF (1999) Diazepam treatment of early signs of exacerbation in schizophrenia. Am J Psychiatry 156:299-303
18. Carter CS, Botvinick MM, Cohen JD (1999) The contribution of the anterior cingulate cortex to executive processes in cognition. Rev Neurosci 10:49-57
19. Costa E, Guidotti A (1996) Benzodiazepines on trial: a research strategy for their rehabilitation. TIPS 17:192-200
20. A receptors. In: Möhler E (ed) Handbook of experimental pharmacology, vol 150. Pharmacology of GABA and glycine neurotransmission. Springer, Berlin Heidelberg New York, pp 227-250
21. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C (2001b) Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 8:723-742
22. A receptors and benzodiazepines: a role for dendritic resident subunit mRNAs. Neuropharmacology 43:925-937
23. Costa E, Davis J, Pesold C, Tueting P, Guidotti A (2002b) The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr Opin Pharmacol 2:56-62
24. Costa E, Grayson DR, Mitchell CP, Tremolizzo L, Veldic M, Guidotti A (2003) GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability. Crit Rev Neurobiol 15:121-142
25. Costa E, Davis JM, Dong E, Grayson DR, Guidotti A, Tremolizzo L, Veldic M (2004) A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol 16:1-24
26. Crestani F, Löw K, Deist R, Mandelli M, Möhler H, Rudolph U (2001) Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 59:442-445
27. Crick FH, Koch C (2003) A framework for consciousness. Nat Neurosci 6:119-126
28. Cruz DA, Eggan SM, Lewis DA (2003) Postnatal development of pre- and post-synaptic GABA markers at chandelier cell inputs to pyramidal neurons in monkey prefrontal cortex. J Comp Neurol 465:385-400
29. Dean B, Hussain T, Hayes W, Scarr E, Kitsoulis S, Hill C, Opeskin K (1999) Changes in serotonin2A and GABA (A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. J Neurochem 72:1593-1599
30. Dean B, Pavey G, McLeod M, Opeskin K, Keks N, Copolov D (2001) A change in the density of [(3)H]flumazenil, but not [(3)H] muscimol binding, in Brodmann's Area 9 from subjects with bipolar disorder. J Affect Disord 66:147-158
31. DeFilipe J, Farinas I (1992) The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol 39:563-607
32. Delini-Stula A, Berdah-Tordjman D, Neumann N (1992) Partial benzodiazepine antagonists in schizophrenia: expectations and present clinical findings. Clin Neuropharmacol 15:405A-406A
33. Dong E, Caruncho H, Liu WS, Smalheiser NR, Grayson DR, Costa E, Guidotti A (2003) The reelin-integrin interaction regulates Arc mRNA translation in synaptoneurosomes. Proc Natl Acad Sci U S A 100:5479-5484
34. Eastwood SL, Harrison PJ (2003) Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol Psychiatry 8:821-831
35. A circuits for visual cortical plasticity. Science 303:1681-1683
36. Fatemi SH, Earle JA, McMenomy T (2000) Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 5:654-663
37. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J Comp Neurol 359:154-194
38. Fritschy JM, Weinman O, Wenzel A, Benke D (1998) Synapse-specific localization of NMDA and GABA (A) receptor subunits revealed by antigen-retrieval immunohistochemistry. J Comp Neurol 390:194-210
39. Giusti P, Guidotti A, Danysz W, Auta J, Costa E (1990) Neuropharmacological evidence for an interaction between the GABA uptake inhibitor CI-966 and anxiolytic benzodiazepines. Drug Dev Rev 21:217-225
40. A receptors. J Pharmacol Exp Ther 266:1018-1028
41. Glantz LA, Lewis DA (2001) Dendritic spine density in schizophrenia and depression. Arch Gen Psychiatry 58:203
42. Guidotti A, Gale K, Suria A, Toffano G (1979) Biochemical evidence for two classes of GABA receptors in rat brain. Brain Res 172:566-571
43. 67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57:1061-1069
44. Halasy K, Buhl EH, Lorinczi Z, Tamas G, Somogyi P (1996) Synaptic target selectivity and input of GABAergic basket and bistratified interneurons in the CA1 area of the rat hippocampus. Hippocampus 6:306-329
45. Hanada S, Mita T, Nishino N (1987) [3H] muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sci 40:259-266
46. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes FM (2002) Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 59:521-529
47. Hensch TK, Stryker MP (2004) Columnar architecture sculpted by GABA circuits in developing cat visual cortex. Science 303:1619-1621
48. A receptor subunit expression in rat neocortex during tolerance to diazepam. Mol Pharmacol 49:822-831
49. Impagnatiello F, Guidotti A, Pesold C, Dwivedi Y, Caruncho H, Pisu M, Uzunov D, Smalheiser N, Davis J, Pandey G, Pappas G, Tueting P, Sharma R, Costa E (1998) A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci U S A 95:15718-15723
50. Ishikawa M, Mizukami K, Iwakiri M, Hidaka S, Asada T (2004) Immunohistochemical and immunoblot study of GABA(A) alpha1 and beta2/3 subunits in the prefrontal cortex of subjects with schizophrenia and bipolar disorder. Neurosci Res 50:77-84
51. Izzo E, Auta J, Impagnatiello F, Pesold C, Guidotti A, Costa E (2001) Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proc Natl Acad Sci U S A 98:3483-3488
52. Jakab RL, Goldman-Rakic PS (2000) Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J Comp Neurol 417(3):337-348
53. Jones EG (1993) GABAergic neurons and their role in cortical plasticity in primates. Cereb Cortex 3:361-372
54. Jones EW (2000) Microcolumns in the cerebral cortex. Proc Natl Acad Sci U S A 97:5019-5021
55. Knable MB, Barci BM, Webster MJ, Woodruff JM, Torrey EF (2004) Molecular abnormalities in the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9:609-620
56. A receptors. Prog Neurobiol 71:67-80
57. Lees AJ, Clarke CR, Harrison MJ (1977) Hallucinations after withdrawal of baclofen. Lancet 16:858
58. A receptor heterogeneity. Nature 335:76-79
59. Lewis DA, Lieberman JA (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28:325-334
60. Lewis DA, Volk DW, Hashimoto T (2004) Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology 174:143-150
61. A receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction. Neuropharmacology 35:1465-1473
62. McBain CJ, Fisahn A (2001) Interneurons unbound. Nat Rev Neurosci 2:11-23
63. Miles R, Toth K, Gulyas AI, Hajos N, Freund GF (1996) Differences between somatic and dendritic inhibition in the hippocampus. Neuron 16:815-823
64. Möhler H, Crestani F, Rudolph U (2001) GABA(A)-receptor subtypes: a new pharmacology. Curr Opin Pharmacol 1:22-25
65. Mountcastle VB (1998) Perceptual Neuroscience. The cerebral cortex. Harvard University Press, Cambridge, MA
66. Niu S, Renfro A, Quattrocchi CC, Sheldon M, D'Arcangelo G (2004) Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway. Neuron 41:71-84
67. Nusser Z, Sieghart W, Benke D, Fritschy JH, Somogyi P (1996) Differential synaptic localization of two major gamma-amino-butyric acid type A receptor alpha subunits on hippocampal pyramidal cells. Proc Natl Acad Sci U S A 93:11939-11944
68. Nyiri G, Freund TF, Somogyi P (2001) Input-dependent synaptic targeting of alpha (2)-subunit-containing GABA (A) receptors in synapses of hippocampal pyramidal cells of the rat. Eur J Neurosci 13:428-442
69. Perlstein WM, Carter CS, Noll DC (2001) Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenics. Am J Psychiatry 158:1105-1113
70. Peters A (1984) Chandelier cells. In: Jones EG, Peters A (eds) Cerebral cortex, vol 1. Plenum Press, NY, pp 361-380
71. Primus RJ, Gallager DW (1992) GABA receptor subunit mRNA levels are differentially influenced by chronic FG7142 and diazepam exposure. Eur J Pharmacol 226:21-28
72. Rao SG, Williams GV, Goldman-Rakic PS (1999) Isodirectional tuning of adjacent interneurons and pyramidal cells during working memory: evidence for microcolumnar organization in PFC. J Neurophysiol 81:1903-1916
73. A blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 20:485-494
74. Rice DS, Curran T (2001) Role of the reelin signaling pathway in central nervous system development. Annu Rev Neurosci 24:1005-1039
75. Rodriguez MA, Caruncho HJ, Costa E, Pesold C, Liu WS, Guidotti A (2002) In Patas monkey GAD67 and reelin mRNA coexpression varies in a manner dependent of layer and cortical area. J Comp Neurol 451:279-288
76. Rosoklija G, Toomayan G, Ellis S, Keilp J, Mann JJ, Latov N, Hays AP, Andrew AJ (2000) Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 57:349-356
77. Sawaguchi T, Iba M (2001) Prefrontal cortical representation of visuospatial working memory in monkeys examined by local inactivation with muscimol. J Neurophysiol 86:2041-2053
78. Sawaguchi T, Matsumura M, Kubota K (1989) Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys. Exp Brain Res 75:457-469
79. Selemon LD, Goldman-Rakic PS (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45:17-25
80. A receptor subtypes. Pharm Rev 47:181-234
81. Skausig OB, Korsgaard S (1977) Hallucinations and baclofen. Lancet 1:158
82. Soghomonian JJ, Martin DL (1998) Two isoforms of glutamate decarboxylase: why? Trends Pharmacol Sci 19:500-505
83. Spencer KM, Nestor PG, Perlmutter R, Niznikiewicz MA, Klump MC, Frumin M, Shenton ME, McCarley RW (2004) Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci 101:17288-17293
84. Stewart O, Schuman EM (2003) Compartmentalized synthesis and degradation of proteins in neurons. Neuron 9:347-359
85. Thompson DM, Guidotti A, Costa E (1995) Imidazenil, a new anxiolytic and anticonvulsant drug, attenuates a benzodiazepine-induced cognition deficit in monkeys. J Pharmacol Exp Ther 273:1307-1312
86. Tremolizzo L, Carboni G, Ruzicka WB, Mitchell CP, Sugaya I, Tueting P, Sharma R, Grayson DR, Costa E, Guidotti A (2002) An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci U S A 99:17095-17100
87. Tremolizzo L, Doueiri MS, Dong E, Grayson DR, Pinna G, Tueting P, Rodriguez-Menendez V, Costa E, Guidotti A (2005) Valproate corrects a methionine-induced schizophrenia neuropathology in mouse. Biol Psychiatry 57:500-509
88. Veldic M, Caruncho H, Liu WS, Davis J, Satta R, Grayson DR, Guidotti A, Costa E (2004) DNA methyltransferase-1 (DNMT1) is selectively overexpressed in telencephalic cortical GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci USA 101:348-353
89. Veldic M, Guidotti A, Maloku E, Davis JM, Costa E (2005) In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci U S A 102:2152-2157
90. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA (2000) Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57:237-245
91. Volk D, Austin M, Pierri J, Sampson A, Lewis D (2001) GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry 158:256-265
92. Wassef A, Baker J, Kochan LD (2003) GABA and schizophrenia: a review of basic science and clinical studies. J Clin Psychopharmacol 23:601-640
93. Weeber EJ, Beffert U, Jones C, Christian JM, Forster E, Sweatt JD, Herz J (2002) Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277:39944-39952
94. Williams GV, Rao SG, Goldman-Rakic PS (2002) The physiological role of 5-HT2A receptors in working memory. J Neurosci 1(22):2843-2854
95. Willins DL, Deutch AY, Roth BL (1997) Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27(1):79-82
96. Wolkowitz DM, Pickar D (1991) Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. Am J Psychiatry 148:714-726
97. Woo TU, Whitehead RE, Melchitzky DS, Lewis DA (1998) A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 95:5341-5346
98. Woo TU, Walsh JP, Benes FM (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61:649-657
99. Wyatt RJ, Benedict A, Davis J (1971) Biochemical and sleep studies of schizophrenia: a review of the literature 1960-1970. Schizophr Bull 4:10-44